{"title":"阿达木单抗诱导的分离性腹膜结核","authors":"M. Saad, F. Ghandour, E. Saikaly","doi":"10.1055/s-0043-1761477","DOIUrl":null,"url":null,"abstract":"Abstract The therapeutic approach to immune-mediated diseases including Crohn's disease has dramatically improved with the introduction of immunomodulators such as anti-tumor necrosis factor (TNF). However, its use is not complication-free, and since its introduction, a growing number of opportunistic infections is being reported in patients under treatment despite all preventive measures taken. Herein, we report a case of adalimumab-induced isolated peritoneal tuberculosis.","PeriodicalId":34302,"journal":{"name":"International Journal of Recent Surgical and Medical Sciences","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adalimumab-Induced Isolated Peritoneal Tuberculosis\",\"authors\":\"M. Saad, F. Ghandour, E. Saikaly\",\"doi\":\"10.1055/s-0043-1761477\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract The therapeutic approach to immune-mediated diseases including Crohn's disease has dramatically improved with the introduction of immunomodulators such as anti-tumor necrosis factor (TNF). However, its use is not complication-free, and since its introduction, a growing number of opportunistic infections is being reported in patients under treatment despite all preventive measures taken. Herein, we report a case of adalimumab-induced isolated peritoneal tuberculosis.\",\"PeriodicalId\":34302,\"journal\":{\"name\":\"International Journal of Recent Surgical and Medical Sciences\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Recent Surgical and Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0043-1761477\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Recent Surgical and Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1761477","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract The therapeutic approach to immune-mediated diseases including Crohn's disease has dramatically improved with the introduction of immunomodulators such as anti-tumor necrosis factor (TNF). However, its use is not complication-free, and since its introduction, a growing number of opportunistic infections is being reported in patients under treatment despite all preventive measures taken. Herein, we report a case of adalimumab-induced isolated peritoneal tuberculosis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
